Your browser doesn't support javascript.
loading
CYP3A4*22 may increase bleeding risk in ticagrelor users.
Liedes, Hilkka; Pajula, Juha; Vuorinen, Anna-Leena; De Pretis, Francesco; van Gils, Mark; Harno, Kari; Lehto, Mika; Niemi, Mikko; Lähteenmäki, Jaakko.
Afiliação
  • Liedes H; VTT Technical Research Centre of Finland Ltd., Oulu, Finland.
  • Pajula J; VTT Technical Research Centre of Finland Ltd., Tampere, Finland.
  • Vuorinen AL; VTT Technical Research Centre of Finland Ltd., Tampere, Finland.
  • De Pretis F; VTT Technical Research Centre of Finland Ltd., Kuopio, Finland.
  • van Gils M; VTT Technical Research Centre of Finland Ltd., Tampere, Finland.
  • Harno K; Department of Health and Social Management, University of Eastern Finland, Kuopio, Finland.
  • Lehto M; Heart and Lung Center, Helsinki University Hospital, Helsinki, Finland.
  • Niemi M; Faculty of Medicine, Clinicum, University of Helsinki, Helsinki, Finland.
  • Lähteenmäki J; Department of Clinical Pharmacology and Individualized Drug Therapy Research Program, University of Helsinki, Helsinki, Finland.
Basic Clin Pharmacol Toxicol ; 133(2): 202-207, 2023 08.
Article em En | MEDLINE | ID: mdl-37162098
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome Coronariana Aguda / Intervenção Coronária Percutânea Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome Coronariana Aguda / Intervenção Coronária Percutânea Idioma: En Ano de publicação: 2023 Tipo de documento: Article